AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Immutac 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Bills Biotech Pvt. Ltd.

Salt Composition

Tacrolimus (0.03% w/w)

Overview Immutac 0.03% Ointment

Topical Immutac 0.03% ointment provides relief from eczema (atopic dermatitis) symptoms. Its mechanism involves modulating immune cell activity responsible for skin inflammation (redness and swelling), thereby reducing itching and improving rash appearance. Apply Immutac 0.03% ointment externally, two to four times daily to affected areas, or as directed by your physician. Gently and evenly distribute the ointment until fully absorbed. Avoid over-application and do not bandage or cover treated skin. Seek medical advice if no improvement is seen after a fortnight or if your condition worsens. Potential side effects include skin redness (erythema), headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Unless medically necessary, use during pregnancy or breastfeeding is generally not advised.

Primary Ingredients of Immutac 0.03% Ointment

The provided information is insufficient.

Uses of Immutac 0.03% Ointment

Managing atopic eczema

Major Benefits of Immutac 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines prior to use. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

Common Side effects of Immutac 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Immutac 0.03% Ointment:

Apply this medication solely to the skin's surface. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines. Ensure the affected area is clean and dry before gently rubbing in the ointment.

How Immutac 0.03% Ointment works:

Isoderm 0.03% topical cream is an immunosuppressive agent that reduces the activity of inflammatory immune cells in the skin. This action lessens skin redness, swelling, and itching, thereby improving atopic dermatitis symptoms.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Immutac 0.03% Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this ointment.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Topical Immutac 0.03% ointment is likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with its use.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Immutac 0.03% Ointment :

Should you forget to apply Immutac 0.03% Ointment, use it at your earliest convenience. Nevertheless, if your next application is imminent, omit the missed dose and resume your normal dosing regimen.

Facts to Know About Immutac 0.03% Ointment

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Type of Medication Cancer treatments
Mechanism of Action Drugs suppressing the immune system: Calcineurin inhibitor class.

FAQs on Immutac 0.03% Ointment

Pimecrolimus 0.03% ointment is an immunomodulatory medication that primarily reduces immune system activity. It's indicated for adults with moderate to severe atopic dermatitis (eczema) who are unresponsive to, or experience adverse effects from, corticosteroid therapies. Atopic dermatitis involves an overactive skin immune response, resulting in inflammation, itching, redness, and dryness. Pimecrolimus 0.03% ointment modifies this aberrant immune response, thereby alleviating skin inflammation and pruritus.
Topical application of Immutac 0.03% Ointment can lead to localized skin reactions such as irritation, burning, and itching. These effects are typically mild to moderate and usually subside within a week. Additional reactions may include redness, warmth, pain, altered sensation, and a rash at the application site. Treatment with this ointment may also increase the likelihood of folliculitis, cold sores, acne breakouts, and widespread herpes simplex infections.
Immutac 0.03% Ointment provides safe and effective short-term management of atopic dermatitis, demonstrating superior safety compared to other immunosuppressant medications. Topical application results in minimal systemic absorption, thus reducing the incidence of adverse effects relative to oral administration.
Immutac 0.03% Ointment is not a controlled substance and does not present a risk of abuse. Controlled substances, by definition, have abuse potential, requiring authorization from both medical professionals and regulatory bodies for dispensing.
Prolonged application of Immutac 0.03% Ointment is associated with a heightened lymphoma risk (a type of lymph node tumor). Limited research indicates a link between Immutac 0.03% Ointment, or comparable treatments, and the development of skin cancer or lymphoma in a small number of users. Seek medical advice if Immutac 0.03% Ointment use exceeds six weeks, or if your eczema symptoms remain unchanged or worsen.
Immutac 0.03% Ointment is non-steroidal. This medication regulates immune system function and treats eczema, particularly atopic dermatitis. A key benefit is its avoidance of skin thinning and other adverse effects associated with steroid use.
Immutac 0.03% Ointment
107
MRP 130
17% off